Anavex Life Sciences Corp (AVXL)

[falconer66a]

When the public learns....

It [AVXL share price] will certainly run up on great results (perhaps to $40), but will eventually be brought back down to $30. Hope I'm wrong, but history shows that $AVXL is being controlled.

But, whatever they are, can the forces or private interests “controlling” the AVXL share price prevail after major news sources tell of profound results with blarcamesine?

How will the vast general retail equity market (Mom and Pop investors) react when AVATAR results appear in the New York Times: “New drug gives girls with Rett syndrome hope. Course of lethal disease reversed, with complete safety. Drug also being tested for Parkinson’s disease dementia and Alzheimer’s disease....?”

Can the ‘cabalists’ keep the investment public from getting excited about blarcamesine, once they are able, in the general press, to read of the profound clinical results it produces in CNS diseases? The Rett results from AVATAR will be first. Then, later, Parkinson’s disease dementia (PDD). Good reporting (From the New York Times?) should certainly tell the sketches of the drug’s mechanism of action (MOA), telling how it activates the sigma-1 receptor protein so that it allows the neuron to produce normal, health-giving proteins (enzymes). There should be no need for reference to some medical magic bean motif. Real cellular biochemistry at play, owned by Anavex Life Sciences Corp (AVXL).